Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VISIPAQUE 320
- Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.
- Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes
- Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
- Pediatric Risk of Hypothyroidism With Iodinated Contrast Media
- A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease
- Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CIN
- Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy
- Efficacy of Low (30ml) Versus Full Dose (100ml) Contrast CT Pulmonary Angiography in Detecting Emboli
- Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography
- Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography
- Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients
- Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis
- Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
- Isovue in Peripheral Digital Subtraction Angiography (DSA)
- Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)
- A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients
- Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography
- Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients
- Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA
- Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material
- Follow-up Study to Previous CARE Trial
- Detection of Pulmonary Embolism With CECT
- Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart
- A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications
- Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart
- Patients With Renal Impairment Undergoing CT
- Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)
- A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography
- RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography
- Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography
- Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)
Clinical trials list
click for details